This systematic review and meta-analysis delved into the world of pancreatic cancer, focusing on frailty. Among 35,191 patients, they discovered that 45% of pancreatic cancer patients were frail. This frailty took a toll, significantly reducing their chances of survival. While the results displayed some variation, they underscored the vital role of assessing frailty in pancreatic cancer cases, offering valuable insights for prognosis and decision-making.
Journal Article by Zhang F, Yan Y and Ge C in Ann Surg Oncol
© 2023. Society of Surgical Oncology.